[email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Population Assessment of Tobacco and Health (PATH) Study--Wave 4 of Data Collection (NIDA)--0925-0664, expiration date 8/31/2018--REVISION--NIDA, NIH, in partnership with the Food and Drug Administration (FDA). Need and Use of Information Collection: This is a revision request (OMB number 0925-0664, expiration date 8/31/2018) for the Population Assessment of Tobacco and Health (PATH) Study to conduct the fourth wave of data collection. The PATH Study is a large national longitudinal cohort study on tobacco use behavior and health among the U.S. household population of adults age 18 and older and youth ages 12 to 17. On an annual basis, the PATH Study conducts interviews with and collects biospecimens from adults and youth to help inform the development, implementation, and evaluation of tobacco-product regulations by FDA in meeting its mission under the Family Smoking Prevention and Tobacco Control Act (TCA) to regulate tobacco products, including tobacco-product advertising, labeling, marketing, constituents, ingredients, and additives. The longitudinal design of the PATH Study provides it with the capacity to measure and report within-person changes and between-person differences in tobacco product use behaviors and health effects within the cohort over time. These data will help to inform regulatory decisions and actions by FDA and FDA's evaluations of associations between its regulations and tobacco use behaviors and health indicators in the population. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 105,079."> [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Population Assessment of Tobacco and Health (PATH) Study--Wave 4 of Data Collection (NIDA)--0925-0664, expiration date 8/31/2018--REVISION--NIDA, NIH, in partnership with the Food and Drug Administration (FDA). Need and Use of Information Collection: This is a revision request (OMB number 0925-0664, expiration date 8/31/2018) for the Population Assessment of Tobacco and Health (PATH) Study to conduct the fourth wave of data collection. The PATH Study is a large national longitudinal cohort study on tobacco use behavior and health among the U.S. household population of adults age 18 and older and youth ages 12 to 17. On an annual basis, the PATH Study conducts interviews with and collects biospecimens from adults and youth to help inform the development, implementation, and evaluation of tobacco-product regulations by FDA in meeting its mission under the Family Smoking Prevention and Tobacco Control Act (TCA) to regulate tobacco products, including tobacco-product advertising, labeling, marketing, constituents, ingredients, and additives. The longitudinal design of the PATH Study provides it with the capacity to measure and report within-person changes and between-person differences in tobacco product use behaviors and health effects within the cohort over time. These data will help to inform regulatory decisions and actions by FDA and FDA's evaluations of associations between its regulations and tobacco use behaviors and health indicators in the population. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 105,079." /> [email protected] Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Population Assessment of Tobacco and Health (PATH) Study--Wave 4 of Data Collection (NIDA)--0925-0664, expiration date 8/31/2018--REVISION--NIDA, NIH, in partnership with the Food and Drug Administration (FDA). Need and Use of Information Collection: This is a revision request (OMB number 0925-0664, expiration date 8/31/2018) for the Population Assessment of Tobacco and Health (PATH) Study to conduct the fourth wave of data collection. The PATH Study is a large national longitudinal cohort study on tobacco use behavior and health among the U.S. household population of adults age 18 and older and youth ages 12 to 17. On an annual basis, the PATH Study conducts interviews with and collects biospecimens from adults and youth to help inform the development, implementation, and evaluation of tobacco-product regulations by FDA in meeting its mission under the Family Smoking Prevention and Tobacco Control Act (TCA) to regulate tobacco products, including tobacco-product advertising, labeling, marketing, constituents, ingredients, and additives. The longitudinal design of the PATH Study provides it with the capacity to measure and report within-person changes and between-person differences in tobacco product use behaviors and health effects within the cohort over time. These data will help to inform regulatory decisions and actions by FDA and FDA's evaluations of associations between its regulations and tobacco use behaviors and health indicators in the population. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 105,079." />
Page Range | 22290-22291 | |
FR Document | 2016-08658 |
[Federal Register Volume 81, Number 73 (Friday, April 15, 2016)] [Notices] [Pages 22290-22291] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-08658] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60-Day Comment Request; Population Assessment of Tobacco and Health (PATH) Study--Wave 4 of Data Collection (NIDA) Summary: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and For Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing or request more information on the proposed project, contact: Kevin P. Conway, Ph.D., Deputy Director, Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 5185; or call non-toll-free number (301) 443-8755; or Email your request, including your address to: [email protected]. Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Population Assessment of Tobacco and Health (PATH) Study--Wave 4 of Data Collection (NIDA)--0925-0664, expiration date 8/31/2018--REVISION--NIDA, NIH, in partnership with the Food and Drug Administration (FDA). Need and Use of Information Collection: This is a revision request (OMB number 0925-0664, expiration date 8/31/2018) for the Population Assessment of Tobacco and Health (PATH) Study to conduct the fourth wave of data collection. The PATH Study is a large national longitudinal cohort study on tobacco use behavior and health among the U.S. household population of adults age 18 and older and youth ages 12 to 17. On an annual basis, the PATH Study conducts interviews with and collects biospecimens from adults and youth to help inform the development, implementation, and evaluation of tobacco-product regulations by FDA in meeting its mission under the Family Smoking Prevention and Tobacco Control Act (TCA) to regulate tobacco products, including tobacco-product advertising, labeling, marketing, constituents, ingredients, and additives. The longitudinal design of the PATH Study provides it with the capacity to measure and report within-person changes and between-person differences in tobacco product use behaviors and health effects within the cohort over time. These data will help to inform regulatory decisions and actions by FDA [[Page 22291]] and FDA's evaluations of associations between its regulations and tobacco use behaviors and health indicators in the population. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 105,079. Estimated Annualized Burden Hours -------------------------------------------------------------------------------------------------------------------------------------------------------- Average Number of Number of burden per Total annual Form name Type of respondent respondents responses per response (in burden hours respondent hours) -------------------------------------------------------------------------------------------------------------------------------------------------------- 1. Household Screener.......................... Households............................. 86,559 1 14/60 20,197 2. Shadow Youth Only Screener.................. Households............................. 56,659 1 5/60 4,722 3. Extended Interview *........................ Adults--Adult respondents--previous 23,414 1 1 23,414 wave. 4. Consent for Extended Interview.............. Adults--New adults and Wave 1 youth 13,984 1 4/60 932 respondents who age up to adult cohort--Wave 4. 5. Individual Screener......................... Adults--New adults..................... 9,152 1 6/60 915 6. Extended Interview *........................ Adults--New adults and Wave 1 youth 10,737 1 68/60 12,169 respondents who age up to adult cohort--Wave 4. 7. Consent for Biological Samples.............. Adults--New adults and Wave 1 youth 10,737 1 5/60 895 respondents who age up to adult cohort--Wave 4. 8. Biospecimen Collection: Urine............... Adults................................. 18,301 1 10/60 3,050 9. Biospecimen Collection: Blood............... Adults--New adults and Wave 1 youth 4,832 1 18/60 1,450 respondents who age up to adult cohort--Wave 4. 10. Tobacco Use Form........................... Adults................................. 23,133 1 5/60 1,928 11. Follow-up/Tracking Participant Information Adults................................. 34,151 2 8/60 9,107 Form. 12. Verification Interview..................... Adults................................. 33,889 1 2/60 1,130 13. Validation Interview....................... Adults................................. 301 1 4/60 20 14. Extended Interview **...................... Youth--Youth respondents--previous wave 8,627 1 35/60 5,032 15. Assent for Extended Interview.............. Youth--New youth and shadow youth who 7,657 1 3/60 383 age up to youth cohort--Wave 4. 16. Extended Interview **...................... Youth--New youth and shadow youth who 6,432 1 45/60 4,824 age up to youth cohort--Wave 4. 17. Assent for urine collection................ Youth.................................. 15,059 1 5/60 1,255 18. Biospecimen Collection: Urine.............. Youth.................................. 10,239 1 10/60 1,707 19. Tobacco Use Form........................... Youth.................................. 10,239 1 5/60 853 20. Parent Interview........................... Adults--Parents of youth respondents-- 8,800 1 16/60 2,347 previous wave. 21. Parent Permission and Consent for Parent Adults--Parents of new youth and 7,657 1 5/60 638 Interview. parents of Shadow youth who age up to youth cohort--Wave 4. 22. Parent Interview........................... Adults--Parents of new youth and 6,561 1 19/60 2,078 parents of shadow youth who age up to youth cohort--Wave 4. 23. Parent permission for urine collection..... Adults--Parents of youth respondents-- 15,360 1 3/60 768 previous wave. 24. Follow-up/Tracking Participant Information Adults--Parents of youth respondents... 15,059 2 8/60 4,016 Form for Youth (completed by parents). 25. Follow-up/Tracking Participant Information Adults--Parents of shadow youth........ 4,684 2 8/60 1,249 Form for sample shadow youth (completed by parents). --------------------------------------------------------------- Total...................................... ....................................... 49,210 496,116 .............. 105,079 -------------------------------------------------------------------------------------------------------------------------------------------------------- Dated: April 5, 2016. Genevieve deAlmeida-Morris, Project Clearance Liaison, National Institute on Drug Abuse, NIH. [FR Doc. 2016-08658 Filed 4-14-16; 8:45 am] BILLING CODE 4140-01-P
Category | Regulatory Information | |
Collection | Federal Register | |
sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
Publisher | Office of the Federal Register, National Archives and Records Administration | |
Section | Notices | |
Dates | Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. | |
FR Citation | 81 FR 22290 |